NMDA receptor upregulation: molecular studies in cultured mouse cortical neurons after chronic antagonist exposure.
We examined the possibility of changes in gene expression of the NMDA receptor subunits after chronic antagonist treatment. Exposure of neurons to the NMDA antagonist D(-)-2-amino-5-phosphonopentanoic acid (AP-5) produced an increase in the levels of the R2B mRNA subunit. Concomitant exposure of neurons to AP-5 and NMDA reversed the upregulation. Chronic AP-5 treatment increased the R1 polypeptide, whereas no change was observed in the levels of mRNA encoding the R1 subunit. A more pronounced increase was observed in the R2A/B polypeptides. These data demonstrate that chronic treatment with NMDA antagonists selectively upregulates the NMDA receptor mRNAs and polypeptides. Furthermore, antagonist treatment produced a differential regulation of the R1, R2A, and R2B subunits in cortical neurons.
Follesa
P
P
Department of Pharmacology, University of Texas Health Science Center, San Antonio 78284-7764, USA.
Ticku
M K
MK
D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured / Q000502:physiology / Q000648:ultrastructure; D002540:Cerebral Cortex / Q000166:cytology; D015870:Gene Expression / Q000187:drug effects; D015151:Immunoblotting; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000502:physiology / Q000648:ultrastructure; D010455:Peptides / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology* / Q000648:ultrastructure; D013997:Time Factors; D015854:Up-Regulation / Q000187:drug effects / Q000235:genetics
D010455:Peptides; D012333:RNA, Messenger; D016194:Receptors, N-Methyl-D-Aspartate; D015763:2-Amino-5-phosphonovalerate